GORD is a common condition that affects between 10% and 30% of people in developed countries.[15]El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2013 Jul 13;63(6):871-80.
http://www.ncbi.nlm.nih.gov/pubmed/23853213?tool=bestpractice.com
There is global variation, with 15.4% prevalence in North America and <10% prevalence in East Asia.[5]Fass R. Gastroesophageal reflux disease. N Engl J Med. 2022 Sep 29;387(13):1207-16.
http://www.ncbi.nlm.nih.gov/pubmed/36170502?tool=bestpractice.com
[15]El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2013 Jul 13;63(6):871-80.
http://www.ncbi.nlm.nih.gov/pubmed/23853213?tool=bestpractice.com
[16]Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018 Mar;67(3):430-40.
http://www.ncbi.nlm.nih.gov/pubmed/28232473?tool=bestpractice.com
All age groups are affected.
There is no evidence for clear predictive factors. Obesity is considered a risk factor for GORD.[16]Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018 Mar;67(3):430-40.
http://www.ncbi.nlm.nih.gov/pubmed/28232473?tool=bestpractice.com
[17]Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199-211.
http://www.ncbi.nlm.nih.gov/pubmed/16061918?tool=bestpractice.com
[18]Kim KJ, Lee BS. Central obesity as a risk factor for non-erosive reflux disease. Yonsei Med J. 2017 Jul;58(4):743-8.
http://www.ncbi.nlm.nih.gov/pubmed/28540986?tool=bestpractice.com
The risk may be related to increasing BMI. In one meta-analysis, the relative risk for symptoms was 1.43 for BMI 25-30 kg/m² and 1.94 for BMI >30 kg/m².[17]Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199-211.
http://www.ncbi.nlm.nih.gov/pubmed/16061918?tool=bestpractice.com
Twin studies suggest that a genetic component may exist.[19]Lembo A, Zaman M, Jones M, et al. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1;25(11):1343-50.
www.doi.org/10.1111/j.1365-2036.2007.03326.x
http://www.ncbi.nlm.nih.gov/pubmed/17509102?tool=bestpractice.com
Alcohol use, smoking, and intake of specific foods (such as coffee, mints, citrus fruits, or fats) may predispose to, or trigger, GORD, but associations are typically modest. Drugs that reduce lower oesophageal sphincter pressure (e.g., calcium-channel blockers) may promote GORD.[20]Lagergren J, Bergstrom R, Adams HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000 Aug 1;133(3):165-75.
http://www.ncbi.nlm.nih.gov/pubmed/10906830?tool=bestpractice.com